 |
市場調查報告書
商品編碼
1412427
格雷夫茲病市場：依治療、診斷分類 - 全球預測 2024-2030Graves Disease Market by Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, Surgery), Diagnosis (Blood Sample, Imaging Tests, Radioactive Iodine Uptake) - Global Forecast 2024-2030 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年格雷夫茲病市場規模為3.6511億美元，2024年將達3.8637億美元，2030年將達5.2213億美元，複合年成長率為5.24%。
格雷夫茲病的全球市場
| 主要市場統計 | |
|---|---|
| 基準年[2023] | 36511萬美元 |
| 預測年份 [2024] | 3.8637 億美元 |
| 預測年份 [2030] | 52213萬美元 |
| 複合年成長率（%） | 5.24% |
FPNV定位矩陣
FPNV 定位矩陣對於評估格雷夫茲病市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。
市場佔有率分析
市場佔有率分析是一種綜合工具，可以對格雷夫茲病市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。
該報告對以下幾個方面提供了寶貴的見解：
1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。
2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。
3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。
本報告解決了以下關鍵問題：
1-格雷夫茲病市場的市場規模和預測是多少？
2-在格雷夫茲病市場預測期內需要考慮投資哪些產品、細分市場、應用和領域？
3-格雷夫茲病市場的技術趨勢和法律規範是什麼？
4-格雷夫茲病市場主要供應商的市場佔有率是多少？
5-進入格雷夫茲病市場的合適型態和策略手段是什麼？
目錄
第1章 前言
第2章調查方法
第3章執行摘要
第4章市場概況
第5章市場洞察
- 市場動態
- 促進因素
- 甲狀腺功能亢進症盛行率增加
- 提高大眾對疾病的認知
- 政府努力改善疾病治療
- 抑制因素
- 對與該疾病相關的嚴重併發症的擔憂
- 機會
- 針對迅速增加的嚴重的治療方法的研究和開發
- 新放射性碘療法和藥物的可用性
- 任務
- 甲狀腺藥物回收數量上升
- 促進因素
- 市場區隔分析
- 市場趨勢分析
- 高通膨的累積效應
- 波特五力分析
- 價值鍊和關鍵路徑分析
- 法律規範
第6章格雷夫茲病市場的治療
- 抗甲狀腺藥物
- 放射性碘治療
- 外科手術
第7章 格雷夫茲病診斷市場
- 血液樣本
- 影像檢查
- 攝入放射性碘
- 超音波
第8章 美洲格雷夫茲病市場
- 阿根廷
- 巴西
- 加拿大
- 墨西哥
- 美國
第9章 亞太地區格雷夫茲病市場
- 澳洲
- 中國
- 印度
- 印尼
- 日本
- 馬來西亞
- 菲律賓
- 新加坡
- 韓國
- 台灣
- 泰國
- 越南
第10章歐洲、中東和非洲格雷夫茲病市場
- 丹麥
- 埃及
- 芬蘭
- 法國
- 德國
- 以色列
- 義大利
- 荷蘭
- 奈及利亞
- 挪威
- 波蘭
- 卡達
- 俄羅斯
- 沙烏地阿拉伯
- 南非
- 西班牙
- 瑞典
- 瑞士
- 土耳其
- 阿拉伯聯合大公國
- 英國
第11章競爭形勢
- FPNV定位矩陣
- 市場佔有率分析：主要企業
- 主要企業競爭情境分析
第12章競爭產品組合
- 主要公司簡介
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- Bayer AG
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Horizon Therapeutics PLC
- Immunovant, Inc.
- Lupin Limited
- Medtronic PLC
- Merck KGaA
- Mylan NV
- Pfizer, Inc.
- RLC Labs, Inc.
- Thermo Fisher Scientific Inc.
- 主要產品系列
第13章附錄
- 討論指南
- 關於許可證和定價
[194 Pages Report] The Graves Disease Market size was estimated at USD 365.11 million in 2023 and expected to reach USD 386.37 million in 2024, at a CAGR 5.24% to reach USD 522.13 million by 2030.
Global Graves Disease Market
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 365.11 million |
| Estimated Year [2024] | USD 386.37 million |
| Forecast Year [2030] | USD 522.13 million |
| CAGR (%) | 5.24% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Graves Disease Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Graves Disease Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Graves Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Horizon Therapeutics PLC, Immunovant, Inc., Lupin Limited, Medtronic PLC, Merck KGaA, Mylan N.V., Pfizer, Inc., RLC Labs, Inc., and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Graves Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Treatment
- Anti-Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
- Diagnosis
- Blood Sample
- Imaging Tests
- Radioactive Iodine Uptake
- Ultrasound
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Graves Disease Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Graves Disease Market?
3. What are the technology trends and regulatory frameworks in the Graves Disease Market?
4. What is the market share of the leading vendors in the Graves Disease Market?
5. Which modes and strategic moves are suitable for entering the Graves Disease Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Graves Disease Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of hyperthyroidism disease
- 5.1.1.2. Rising awareness regarding disease among the population
- 5.1.1.3. Government initiatives to improve disease treatment
- 5.1.2. Restraints
- 5.1.2.1. Concern with serious complication associated with disease
- 5.1.3. Opportunities
- 5.1.3.1. Surging research and development of grave disease treatment
- 5.1.3.2. Availability of new radioiodine therapy and medications
- 5.1.4. Challenges
- 5.1.4.1. Increasing recalls of thyroid drugs
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Graves Disease Market, by Treatment
- 6.1. Introduction
- 6.2. Anti-Thyroid Medication
- 6.3. Radioactive Iodine Therapy
- 6.4. Surgery
7. Graves Disease Market, by Diagnosis
- 7.1. Introduction
- 7.2. Blood Sample
- 7.3. Imaging Tests
- 7.4. Radioactive Iodine Uptake
- 7.5. Ultrasound
8. Americas Graves Disease Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Graves Disease Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Graves Disease Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Abbott Laboratories
- 12.1.2. AbbVie Inc.
- 12.1.3. Amgen Inc.
- 12.1.4. Bayer AG
- 12.1.5. Eli Lilly and Company
- 12.1.6. F. Hoffmann-La Roche Ltd.
- 12.1.7. Horizon Therapeutics PLC
- 12.1.8. Immunovant, Inc.
- 12.1.9. Lupin Limited
- 12.1.10. Medtronic PLC
- 12.1.11. Merck KGaA
- 12.1.12. Mylan N.V.
- 12.1.13. Pfizer, Inc.
- 12.1.14. RLC Labs, Inc.
- 12.1.15. Thermo Fisher Scientific Inc.
- 12.2. Key Product Portfolio
13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
LIST OF FIGURES
- FIGURE 1. GRAVES DISEASE MARKET RESEARCH PROCESS
- FIGURE 2. GRAVES DISEASE MARKET SIZE, 2023 VS 2030
- FIGURE 3. GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GRAVES DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GRAVES DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GRAVES DISEASE MARKET DYNAMICS
- FIGURE 7. GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
- FIGURE 8. GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
- FIGURE 10. GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2023
LIST OF TABLES
- TABLE 1. GRAVES DISEASE MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 6. GRAVES DISEASE MARKET SIZE, BY ANTI-THYROID MEDICATION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. GRAVES DISEASE MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 10. GRAVES DISEASE MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GRAVES DISEASE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. AMERICAS GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 15. AMERICAS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 17. ARGENTINA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 18. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 19. BRAZIL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 20. BRAZIL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 21. CANADA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 22. CANADA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 23. MEXICO GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 24. MEXICO GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 25. UNITED STATES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 26. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 27. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 28. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 29. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 30. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 31. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 32. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 33. CHINA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 34. CHINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 35. INDIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 36. INDIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 37. INDONESIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 38. INDONESIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 39. JAPAN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 40. JAPAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 41. MALAYSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 42. MALAYSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 43. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 44. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 45. SINGAPORE GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 46. SINGAPORE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 47. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 48. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 49. TAIWAN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 50. TAIWAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 51. THAILAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 52. THAILAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 53. VIETNAM GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 54. VIETNAM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 55. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 56. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 57. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 58. DENMARK GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 59. DENMARK GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 60. EGYPT GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 61. EGYPT GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 62. FINLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 63. FINLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 64. FRANCE GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 65. FRANCE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 66. GERMANY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 67. GERMANY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 68. ISRAEL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 69. ISRAEL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 70. ITALY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 71. ITALY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 72. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 73. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 74. NIGERIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 75. NIGERIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 76. NORWAY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 77. NORWAY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 78. POLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 79. POLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 80. QATAR GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 81. QATAR GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 82. RUSSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 83. RUSSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 84. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 85. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 86. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 87. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 88. SPAIN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 89. SPAIN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 90. SWEDEN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 91. SWEDEN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 92. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 93. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 94. TURKEY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 95. TURKEY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 96. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 97. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 98. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 99. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
- TABLE 100. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
- TABLE 101. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 102. GRAVES DISEASE MARKET LICENSE & PRICING
